InVivo Therapeutics Holdings Corp. (NVIV) Touches $1.17 Low on May, 15; HEMFOSA FASTIGHETER AB ORDINARY SHARES (HMFFF) SI Decreased By 0.52%

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) Logo

The stock of InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) reached all time low today, May, 15 and still has $1.13 target or 3.00% below today’s $1.17 share price. This indicates more downside for the $10.89M company. This technical setup was reported by If the $1.13 PT is reached, the company will be worth $326,820 less. The stock decreased 4.88% or $0.06 during the last trading session, reaching $1.17. About 42,183 shares traded. InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) has declined 87.15% since May 15, 2018 and is downtrending. It has underperformed by 91.52% the SP500. Some Historical NVIV News: 09/04/2018 – INVIVO THERAPEUTICS HOLDINGS – IN PROCESS OF FINALIZING LEASE ASSIGNMENT, EXPECTED TO RESULT IN LEASE-RELATED SAVINGS OF ABOUT $3 MLN THROUGH 2019; 04/04/2018 – Sangamo Announces Publication In Molecular Therapy Of Preclinical Study Data From

... read more at: